Vyleesi
Ended Awarded Last action
- Contract number
- 36C26026F0217
- Awardee
-
Cosette Pharmaceuticals, Inc. UEI HDQFPZ3SBV24
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $4,159
Award facts
- Contract value 100% obligated
- $4,159.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- South Plainfield, NJ 07080, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs (VA), through Veterans Integrated Service Network (VISN) 20, awarded a delivery order valued at $4,159.20 to Cosette Pharmaceuticals, Inc. on March 16, 2026, with an ultimate completion date of April 16, 2026. This firm-fixed-price delivery order procures VYLEESI (bremelanotide) 1.75MG/0.3ML autoinjectors under the General Services Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle. The award carries no set-aside designation and represents a continuation of Cosette Pharmaceuticals' established role as a pharmaceutical supplier to VA medical facilities across multiple VISN regions. The place of performance is identified as South Plainfield, New Jersey, which aligns with the vendor's headquarters location.
Cosette Pharmaceuticals, Inc., a for-profit pharmaceutical supply and distribution company registered in the System for Award Management since June 2019, has demonstrated consistent capability in fulfilling specialized pharmaceutical requirements for the VA. The company's track record includes multiple recent delivery order awards for VYLEESI products across different VISN regions, as well as other pharmaceutical supplies such as Clomiphene Citrate Tablets. This delivery order leverages the efficiency of the FSS-61-IB contract vehicle, which enables VA medical facilities to procure pre-negotiated pharmaceutical products directly, supporting the VA's mission to deliver comprehensive healthcare services to the veteran population.
Quick answers
Who was awarded contract 36C26026F0217?
36C26026F0217 was awarded to Cosette Pharmaceuticals, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on March 16, 2026.
How much is contract 36C26026F0217 worth?
The government has obligated $4,159 on 36C26026F0217.
Is contract 36C26026F0217 an order under another contract?
Yes. 36C26026F0217 is a delivery order under 36F79720D0191, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26026F0217 competed?
The extent of competition for 36C26026F0217 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award